Purchase Order HT942525P0005

This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Acatechol, Inc., a small business, for a Small Business Innovation Research (SBIR) Phase I research and development project. The contract, valued at $249,999.84, is for the development of a bioinspired chitosan-based hydrogel for neuroprotective treatment of traumatic brain injury. The project, titled "Bioinspired Chitosan-Based Hydrogels for Neuroprotective Treatment for Traumatic Brain Injury," is...

This is a $249,999.06 firm fixed price purchase order awarded by the Defense Health Agency (DHA) to Luna Labs USA LLC, a small business manufacturer and R&D firm, under the SBIR (Small Business Innovation Research) program. The contract is for a Phase I research and development project titled "Brain Shield: A Field-Deployable Hydrogel Drug Delivery System for Localized Treatment of TBI (Traumatic Brain Injury)." The research aims to develop an advanced hydrogel-based drug...

This federal contract award is for a Small Business Innovation Research (SBIR) Phase I effort by Altrazeal Life Sciences Inc., doing business as Uluru, to develop an "Innovative Adaptive Drug Delivery System Enhanced Neuroprotection Repair Traumatic Brain Injuries from Penetrating Trauma Open Skull Fractures in Low Resource Envir." The $249,999.96 firm fixed-price contract was awarded by the Defense Health Agency (DHA) on October 7, 2024 and runs through May 6, 2025. The research is...

<p>This is a $230,867.83 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Sunfire Biotechnologies LLC, a minority-owned, self-certified small disadvantaged business. The contract is for medical research and development under the DHA's Small Business Innovation Research (SBIR) Phase I program. The contract is set aside for small businesses and has an August 31, 2021 completion date.</p>

<p>The Defense Health Agency (DHA) awarded a Small Business Innovation Research (SBIR) Phase I contract worth $147,960.00 to Fosmo Med, Inc., a minority-owned, self-certified small disadvantaged business and manufacturer of goods. The contract, designated as a Total Small Business set-aside, has a completion date of December 25, 2018 and is a Definitive Contract with a Firm Fixed Price pricing type. The place of performance is San Mateo, CA 94401, USA.</p>

This is a federal contract award issued by the Defense Health Agency (DHA) to the Medical Technology Enterprise Consortium (MTEC), a non-profit organization that serves as a medical technology accelerator for the Department of Defense. The $1,340,612.39 award is for the &quot;Development of a Fieldable Direct Osmotherapy Device for the Point-of-Injury Reduction of Cerebral Edema Following Penetrating Traumatic Brain Injury.&quot; This project aims to develop innovative medical products to...

This is a Cost Plus Fixed Fee contract awarded by the Defense Health Agency (DHA) under the Small Business Innovation Research (SBIR) program. The prime contractor is TDA Research, Inc., a for-profit subchapter S corporation located in Wheat Ridge, Colorado. The contract was set aside for small businesses and has a ceiling value of $1,996,362.19. It covers SBIR Phase II research and development efforts, which typically involve further development and demonstration of technologies that showed...

This is a $1,299,944.94 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Intelligent Optical Systems, Inc., a small business manufacturer of optical sensing and instrumentation technologies. The contract is for a SBIR Phase II project titled &quot;Enhanced Rapid Assay for Monitoring Immunosuppressant Drugs in Whole Blood.&quot; The contract is designated as a Total Small Business set-aside and has an ultimate completion date of July 24, 2026. This award is part of the...

<p>This is a $1,999,175.53 firm fixed-price Definitive Contract awarded by the Defense Health Agency (DHA), a defense agency, to Technovax Inc., a small disadvantaged business, under the SBIR (Small Business Innovation Research) Phase II program. The contract is for research and development work, with a period of performance ending on February 16, 2021. The contract was set aside for small businesses.</p>

This contract award is for a NEW MEDICAL RESEARCH AND DEVELOPMENT CONTRACT under the Defense Health Agency's (DHA) Phase I SBIR 19.1 program, with the project titled &quot;REMIDE (RELIABLE MEDICAL INFORMATION DELIVERY IN DIL ENVIRONMENTS)&quot;. The contract was awarded to the prime contractor Architecture Technology Inc., doing business as Architecture Technology Corp, a for-profit organization that provides research, engineering, and technical services to federal government agencies. The...